Effect of Shenling Baizhu San on Murine Model of IBD Induced by DSS in Mice by Regulating Autophagy

Yu YOU; Yu-hui LIU; Lin LI; Wang-di LIAO

doi:10.13422/j.cnki.syfjx.20190504

您当前的位置：

首页 >

文章列表页 >

Effect of Shenling Baizhu San on Murine Model of IBD Induced by DSS in Mice by Regulating Autophagy

Classic Prescriptions | 更新时间：2021-02-09

- Effect of Shenling Baizhu San on Murine Model of IBD Induced by DSS in Mice by Regulating Autophagy
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 5, Pages: 43-49(2019)
- 作者机构：
  
  1.南昌大学　第一附属医院，南昌　 330006；
  2.江西中医药大学，南昌　 330004
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20190504
  CLC： R2-0;R22;R285.5;R289
- Received：13 August 2018，
  
  Published Online：21 November 2018，
  
  Published：05 March 2019
- 稿件说明：
移动端阅览
Yu YOU, Yu-hui LIU, Lin LI, et al. Effect of Shenling Baizhu San on Murine Model of IBD Induced by DSS in Mice by Regulating Autophagy[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(5): 43-49.
DOI：

Yu YOU, Yu-hui LIU, Lin LI, et al. Effect of Shenling Baizhu San on Murine Model of IBD Induced by DSS in Mice by Regulating Autophagy[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(5): 43-49. DOI： 10.13422/j.cnki.syfjx.20190504.

摘要

目的：

探究参苓白术散对5%葡聚糖硫酸钠(DSS)所致BALB/c小鼠炎症性肠病(IBD)的改善作用与肠上皮细胞自噬的关系。

方法：

84只BALB/c小鼠，除正常组之外，5% DSS自由饮用7d诱导急性炎症性肠病，治疗组分别给予参苓白术散高、中、低剂量组(12

3g·kg

－1

·d

－1

)，美沙拉嗪组(2g·kg

－1

·d

－1

)，自噬诱导剂雷帕霉素组(4mg·kg

－1

·d

－1

)灌胃。观察小鼠体质量、粪便性状、隐血便血，计算疾病活动度(DAI)积分；酶联免疫吸附测定(ELISA)检测小鼠血清中炎症因子白细胞介素-8(IL-8)，IL-10含量；苏木素-伊红(HE)染色观察结肠组织病理学改变；免疫组化检测肠组织中肿瘤坏死因子-

(TNF-

)和IL-1

的表达；共聚焦显微镜观察肠上皮细胞自噬体形成情况；蛋白免疫印迹法(Western blot)检测自噬相关通路蛋白的水平。

结果：

与模型组比较，参苓白术散组小鼠隐血，便血，体质量下降，DAI积分，病理改变等均改善；与正常组比较，模型组小鼠血清中IL-10含量显著降低，IL-8含量显著升高(

0.01)，小鼠肠组织中IL-1

和TNF-

的表达明显升高(

0.01)，肠上皮细胞自噬体减少，微管轻链蛋白3(LC3)-Ⅱ/LC3-Ⅰ比值含量显著降低(

0.01)；与模型组比较，参苓白术散可以升高小鼠血清IL-10含量，降低IL-8含量明显(

0.05，

0.01)，明显降低IL-1

和TNF-

的表达(

0.05)，参芩白术散高剂量组、雷帕霉素及美沙拉嗪组肠上皮细胞自噬体形成显著增多，显著升高LC3 Ⅱ/LC3 Ⅰ含量。

结论：

参苓白术散抗DSS诱导的IBD的作用与抑制炎症及调节肠上皮细胞自噬有关。

Abstract

Objective:

To investigate the mechanism of Shenling Baizhu San (SLBZS) in treating dextra sulfate sodium (DSS)-induced inflammatory bowel disease (IBD) mice and its relationship with autophagy.

Method:

SPF BALB/c mice were randomly divided into control group

model group

mesalazine group

low

medium and high-dose SLBZS groups

and autophagy inducer rapamycin group.The IBD mice were fed with 5% DSS in their drinking water for 7 days

and the control mice received only water.SLBZS groups were given SLBZS at doses of 3

12g·kg

-1

·d

-1

positive group was given mesalazine sustained release granules at the dose of 2g·kg

-1

·d

-1

rapamycin group was given rapamycin at the dose of 4mg·kg

-1

·d

-1

and control mice was given the same volume of normal saline by gavage.The mice weight

stool occult blood in stool

score of disease activity (DAI)

pathological examination of intestinal mucosal lesions integral were observed after 7 days. interleukin(IL)-8 and IL-10 in serum were detected by enzyme-linked immuno sorbent assay(ELISA)

vascular tissue samples were prepared for the detection of tumor neorosis factor-(TNF-

) and IL-1

and transmission electron microscope and Western blot were used to detect the formation of autophagosomes and the level of autophagy.

Result:

The body mass decrease

the colon length

disease activity scoring

and histological scoring of SLBZS group were better than those of DSS group. Compared with control group

the level of IL-10 decreased

while the level of IL-8 increased obviously (

0.01)

IL-1 and TNF-

expressions significantly up-regulated(

0.01)

the formation of autophagosome decreased

and LC3-Ⅱ/Ⅰ level down-regulated. Compared with IBD group

SLBZS group showed increase in formation of autophagosome and LC3-Ⅱ/Ⅰ and IL-10

decrease in IL-8(

0.05

0.01)

and down-regulation in IL-1 and TNF-

expressions(

0.01). These results were observed in mesalazine group and rapamycin group.

Conclusion:

Shenling Baizhu San can significantly inhibit the IBD by regulating autophagy and suppressing inflammation.

关键词

Keywords

references

Singh S , Chowdhry M , Umar S , et al . Variations in the medical treatment of inflammatory bowel disease among gastroenterologists [J]. Gastroenterol Rep , 2018 , 6 ( 1 ): 61 - 64 .

LIU Y H , DING Y , GAO C C , et al . Functional macrophages and gastrointestinal disorders [J]. World J Gastroenterol , 2018 , 24 ( 11 ): 1181 - 1195 .

Martini E , Krug S M , Siegmund B , et al . Mend your fences: the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease [J]. Cell Mol Gas Hep , 2017 , 4 ( 1 ): 33 - 46 .

张琮，王嘉正，沈玉洁，等．自噬诱导剂 pp242对肿瘤坏死因子-α所致肠屏障损伤的影响 [J]. 胃肠病学， 2017 , 22 ( 6 ): 337 - 340 .

陆忠凯，陈志荣．炎症性肠病患者自噬相关IRGM基因的表达变化及临床意义 [J]. 胃肠病学和肝病学杂志， 2013 , 22 ( 10 ): 1010 - 1012 .

徐昌君，王鹏飞，刘杨，等 . 黄芪甲苷对特发性肺纤维化自噬活性作用及PI3K/Akt/mTOR信号调控的影响 [J]. 中国实验方剂学杂志， 2017 , 23 ( 18 ): 75 - 82 .

焦延娜，韩淑燕 . 抗癌中药单体对肿瘤细胞自噬的调控 [J]. 中国实验方剂学杂志， 2017 , 23 ( 7 ): 206 - 214 .

刘玉晖，胡婕，易文凤，等．参苓白术散治疗炎症性肠病与肠上皮细胞紧密连接的关系探讨 [J]. 中国实验方剂学杂志， 2015 , 21 ( 3 ): 130 - 133 .

刘玉晖，刘志勇，廖旺娣，等．参苓白术散抗脂多糖致肠隐窝上皮细胞损伤的作用及机制 [J]. 中药新药与临床药理， 2016 , 27 ( 1 ): 1 - 5 .

YOU Y , FU J J , MENG J , et al . Effect of N-acetylcysteine on the murine model of colitis induced by dextran sodium sulfate through up-regulating PON1 activity [J]. Dig Dis Sci , 2009 , 54 ( 8 ): 1643 - 1650 .

YEN Y H , PU C M , LIU C W , et al . Curcumin accelerates cutaneous wound healing via multiple biological actions: the involvement of TNF-α，MMP-9, α-SMA, and collagen [J]. Int Wound J , 2018 , 5 ( 4 ): 605 - 617 .

Majumder K , Mine Y , WU J. The potential of food protein-derived anti-inflammatory peptides against various chronic inflammatory diseases [J]. J Sci Food Agric , 2016 , 96 ( 7 ): 2303 - 2311 .

Manresa M C , Taylor C T. Hypoxia inducible factor (HIF) hydroxylases as regulators of intestinal epithelial barrier function [J]. Cell Mol Gas Hep , 2017 , 3 ( 3 ): 303 - 315 .

郑晴，包怡敏．中药对心肌缺血再灌注损伤过程中自噬的调控 [J]. 中国中药杂志， 2017 , 42 ( 15 ): 2925 - 2929 .

涂玥，孙伟，陈涤平，等．自噬调控肾脏衰老的分子机制及中药的干预作用 [J]. 中国中药杂志， 2016 , 41 ( 21 ): 3914 - 3918 .

Serbati N , Senhaji N , Diakite B , et al . IL23R and ATG16L1 variants in moroccan patients with inflammatory bowel disease [J]. BMC Res Notes , 2014 , 26 ( 7 ): 570 .

Baskaran K , Pugazhendhi S , Ramakrishna B S. Association of IRGM gene mutations with inflammatory bowel disease in the Indian population [J]. PLoS One , 2014 , 9 ( 9 ): e106863 .

Paul S , Kashyap A K , JIA W , et al . Selective autophagy of the adaptor protein Bcl10 modulates T cell receptor activation of NF-κB [J]. Immunity , 2012 , 36 ( 6 ): 947 - 958 .

Castillo F , Dekonenko A , Arko-Mensah J , et al . Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation [J]. Proc Natl Acad Sci USA , 2012 , 109 ( 46 ): 3168 - 3176 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Shenling Baizhu San on Expressions of NLPR3, NLPR6 Protein and Related Inflammatory Factors in Mice with Ulcerative Colitis

Exploring Mechanism of Kelong Capsules in Treatment of Benign Prostatic Hyperplasia Based on Nrf2 Pathway and Macrophage Activation

Zhenzhu Tiaozhi Capsules Reduce Renal Lipid Deposition and Inflammation in Mouse Model of Diabetic Kidney Disease via SCAP-SREBP-1c/NLRP3 Signaling Pathway

Multidimensional Analysis of Mechanisms of Nuciferine Against Cerebral Ischemia Based on Transcriptomic Data

Mechanism of Modified Danggui Shaoyaosan in Improving Inflammation and Apoptosis in Acne via Regulating JNK/p38 MAPK Pathway

Related Author

Jia-jun ZHANG

Jia-xi SHI

Juan HUANG

Xu-guang SHI

Cui-ying LIU

Qi WANG

SONG Guanhui

FAN Danping

Related Institution

School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine

First College of Clinical Medicine, Guangzhou University of Chinese Medicine

Foshan Chinese Hospital

Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine

The First Clinical Medical College of Shaanxi University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰